FERMENTA BIOTECH LIMITED (FERMENTA.BO)
INR 393.0
(-0.57%)
INR 393.0
(-0.57%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -230.59 Million INR | 54.85% |
| 2022 | -510.75 Million INR | -430.65% |
| 2021 | 154.47 Million INR | -66.06% |
| 2020 | 455.06 Million INR | -23.55% |
| 2019 | 595.26 Million INR | -49.32% |
| 2018 | 1.17 Billion INR | 248.38% |
| 2017 | 337.14 Million INR | 395.11% |
| 2016 | -114.24 Million INR | -907.25% |
| 2015 | -11.34 Million INR | -344.55% |
| 2014 | 4.63 Million INR | -94.11% |
| 2013 | 78.78 Million INR | 89.43% |
| 2012 | 41.59 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -58.19 Million INR | 16.16% |
| 2023 Q3 | 98.48 Million INR | 135.43% |
| 2023 Q4 | -69.4 Million INR | -170.47% |
| 2023 FY | -230.59 Million INR | 54.85% |
| 2023 Q1 | 18.32 Million INR | 148.92% |
| 2023 Q2 | -278 Million INR | -1616.98% |
| 2022 FY | -510.75 Million INR | -430.65% |
| 2022 Q3 | -373.91 Million INR | -364.41% |
| 2022 Q1 | -23.09 Million INR | -130.07% |
| 2022 Q4 | -37.45 Million INR | 89.98% |
| 2022 Q2 | -80.51 Million INR | -248.67% |
| 2021 Q4 | 76.79 Million INR | 195.47% |
| 2021 Q1 | 113.12 Million INR | 52.96% |
| 2021 FY | 154.47 Million INR | -66.06% |
| 2021 Q2 | 44.98 Million INR | -60.23% |
| 2021 Q3 | -80.43 Million INR | -278.79% |
| 2020 Q4 | 73.95 Million INR | -24.52% |
| 2020 Q3 | 97.97 Million INR | -33.4% |
| 2020 Q2 | 147.1 Million INR | 8.14% |
| 2020 FY | 455.06 Million INR | -23.55% |
| 2020 Q1 | 136.03 Million INR | 333.71% |
| 2019 Q2 | 326.81 Million INR | 150.7% |
| 2019 Q4 | 31.36 Million INR | -67.51% |
| 2019 Q1 | 130.36 Million INR | -70.59% |
| 2019 Q3 | 96.52 Million INR | -70.47% |
| 2019 FY | 595.26 Million INR | -49.32% |
| 2018 Q2 | 319.55 Million INR | 109.38% |
| 2018 FY | 1.17 Billion INR | 248.38% |
| 2018 Q4 | 443.25 Million INR | 71.07% |
| 2018 Q3 | 259.1 Million INR | -18.92% |
| 2018 Q1 | 152.61 Million INR | 0.06% |
| 2017 Q3 | 189.71 Million INR | 439.2% |
| 2017 Q4 | 152.52 Million INR | -19.6% |
| 2017 Q2 | 35.18 Million INR | 187.35% |
| 2017 FY | 337.14 Million INR | 395.11% |
| 2017 Q1 | -40.28 Million INR | 83.94% |
| 2016 FY | -114.24 Million INR | -907.25% |
| 2016 Q1 | 113 Thousand INR | 100.38% |
| 2016 Q2 | 193.94 Million INR | 171534.51% |
| 2016 Q3 | -57.54 Million INR | -129.67% |
| 2016 Q4 | -250.76 Million INR | -335.8% |
| 2015 Q2 | 2.13 Million INR | -83.47% |
| 2015 Q4 | -29.62 Million INR | -1015.33% |
| 2015 Q3 | 3.23 Million INR | 51.64% |
| 2015 FY | -11.34 Million INR | -344.55% |
| 2015 Q1 | 12.9 Million INR | -43.34% |
| 2014 Q3 | -25.67 Million INR | -3158.76% |
| 2014 Q1 | 8.32 Million INR | -76.1% |
| 2014 FY | 4.63 Million INR | -94.11% |
| 2014 Q2 | -788 Thousand INR | -109.47% |
| 2014 Q4 | 22.78 Million INR | 188.71% |
| 2013 Q2 | -929 Thousand INR | -109.98% |
| 2013 Q4 | 34.83 Million INR | -2.06% |
| 2013 Q3 | 35.56 Million INR | 3928.63% |
| 2013 Q1 | 9.31 Million INR | 256.6% |
| 2013 FY | 78.78 Million INR | 89.43% |
| 2012 FY | 41.59 Million INR | 0.0% |
| 2012 Q4 | -5.94 Million INR | -212.7% |
| 2012 Q3 | 5.27 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 2.76 Million INR | 8442.909% |
| Biocon Limited | 10.22 Billion INR | 102.255% |
| Blue Jet Healthcare Limited | 1.63 Billion INR | 114.082% |
| Concord Biotech Limited | 3.08 Billion INR | 107.484% |
| Dishman Carbogen Amcis Limited | -1.53 Billion INR | 84.972% |
| GENOMIC VALLEY BIOTECH LIMITED | 151.81 Thousand INR | 151991.08% |
| Lyka Labs Limited | -24.89 Million INR | -826.32% |
| Panacea Biotec Limited | -11.73 Million INR | -1865.882% |
| SAMSRITA LABS LIMITED | -2.62 Million INR | -8693.228% |
| Servoteach Industries Limited | -2.37 Million INR | -9613.479% |
| SMS Lifesciences India Limited | 90.92 Million INR | 353.605% |
| Supriya Lifescience Limited | 1.19 Billion INR | 119.359% |
| Syngene International Limited | 5.1 Billion INR | 104.522% |
| TAKE Solutions Limited | -1.19 Billion INR | 80.722% |
| Titan Biotech Limited | 248.53 Million INR | 192.785% |
| Transgene Biotek Limited | -6.55 Million INR | -3417.895% |
| Vanta Bioscience Limited | -23.15 Million INR | -895.717% |